These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1713888)

  • 21. [Morphological, ultrastructural, cytochemical and functional analysis of neutrophils deficient in myeloperoxidase].
    Lanza F; Spisani S; Fietta A; Traniello S
    Boll Soc Ital Biol Sper; 1985 Mar; 61(3):453-9. PubMed ID: 2992545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
    Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
    Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Myeloperoxidase deficiency of the peripheral blood neutrophils and the incidence of infectious complications in patients with acute myeloblastic leukemia].
    Tishchenko LM; Guseva SA
    Vrach Delo; 1989 Mar; (3):49-51. PubMed ID: 2546323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Study on neutrophil enzymes in atopic disease.
    Xue ZY; Lu XQ; Yu ML
    Chin Med J (Engl); 1993 Sep; 106(9):703-6. PubMed ID: 8287709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein oxidation status in patients with ankylosing spondylitis.
    Yazici C; Köse K; Calis M; Kuzugüden S; Kirnap M
    Rheumatology (Oxford); 2004 Oct; 43(10):1235-9. PubMed ID: 15292529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tissue migration of neutrophil granulocytes in the course of antiproliferative treatment in Hodgkin's disease].
    Wysocki H; Wierusz-Wysocka B; Prazmowska-Owczarek B; Hansz J
    Acta Haematol Pol; 1976; 7(2):117-22. PubMed ID: 936962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of O6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma.
    Sagher D; Karrison T; Schwartz JL; Larson RA; Strauss B
    Cancer Res; 1989 Oct; 49(19):5339-44. PubMed ID: 2548719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of geomagnetic field on leukocyte count in cancer patients. Role of nitric oxide].
    Iamshanov VA; Kotelevskiĭ VK
    Vopr Onkol; 2007; 53(4):456-60. PubMed ID: 17969411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Myeloperoxidase of neutrophils and its possible role in lipid peroxidation processes in arteriosclerosis].
    Davidenkova EF; Shafron MG
    Klin Med (Mosk); 1989 Jun; 67(6):56-8. PubMed ID: 2550701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical comparison of myeloperoxidase of leukemic myeloblasts and normal neutrophilic granulocytes.
    Morishita K; Asano S; Fujii H; Yokota J; Kodo H; Miwa S
    J Appl Biochem; 1984; 6(5-6):271-7. PubMed ID: 6100291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relationship of myeloperoxidase activity to neutrophil maturity and other hematologic indicators of infection.
    Kaplow LS
    Blood Cells; 1986; 12(1):153-65. PubMed ID: 3024763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.
    Oudejans JJ; Kummer JA; Jiwa M; van der Valk P; Ossenkoppele GJ; Kluin PM; Kluin-Nelemans JC; Meijer CJ
    Am J Pathol; 1996 Jan; 148(1):233-40. PubMed ID: 8546210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Histochemical characteristics of neutrophils of the peripheral blood in patients with cancer of the stomach].
    Moshchynski P; Slovin'ski S; Moshchynski P
    Vopr Onkol; 1988; 34(6):682-5. PubMed ID: 2839937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
    Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
    Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Disorders of the hematopoietic system in patients with Hodgkin's disease before treatment].
    Paluszewska M; Rokicka M; Kuratowska Z
    Pol Tyg Lek; 1987 Apr; 42(17):497-9. PubMed ID: 3615279
    [No Abstract]   [Full Text] [Related]  

  • 36. [Characteristics of cardiac rhythm and the peroxidase activity of blood in patients with ischemic heart disease treated by hyperbaric oxygenation].
    Fokina TS; Maksimova IE; Iuryshev VF
    Fiziol Zh (1978); 1991; 37(4):89-91. PubMed ID: 1663872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse.
    Bendix-Hansen K; Nielsen HK
    Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neutrophil peroxidase activity in the peripheral blood of patients with rubromycosis of the feet].
    Fedorenko AE; Svirid SG
    Vrach Delo; 1986 Dec; (12):83-4. PubMed ID: 3029997
    [No Abstract]   [Full Text] [Related]  

  • 39. [The plasma level of sL-selectin, myeloperoxidase and granulocyte-colony stimulating factor (G-CSF) in breast cancer patients in the course of chemotherapy].
    Czygier M; Ławicki S; Uścinowicz A; Szmitkowski M
    Przegl Lek; 2008; 65(3):115-8. PubMed ID: 18624117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collagenolytic activity in leukocytes isolated from patients with leukemias and Hodgkin's disease.
    Kucharz E; Drózdz M
    Neoplasma; 1978; 25(5):621-4. PubMed ID: 216937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.